PUBLISHER: The Business Research Company | PRODUCT CODE: 1668413
PUBLISHER: The Business Research Company | PRODUCT CODE: 1668413
Microarray is a widely employed laboratory technique that involves affixing numerous known nucleic acid fragments-ranging from tens of thousands to millions-onto a solid surface, commonly referred to as a chip. This method finds frequent application in scientific and medical research, serving purposes such as detecting specific DNA sequences and assessing gene expression.
The primary categories of microarrays include DNA microarray, protein microarray, and others. A DNA microarray consists of small DNA spots affixed to a solid substrate, utilized to determine the presence of gene mutations, such as those in BRCA1 or BRCA2, within the DNA of a particular individual. This technology is employed across various domains, including disease diagnosis, cancer genomic analysis, drug discovery, genomic sequencing, expression analysis, and toxicological research. Its users span the pharmaceutical and biotechnology industries, academic and research laboratories, and other end-users.
The microarray market research report is one of a series of new reports from The Business Research Company that provides microarray market statistics, including the microarray industry's global market size, regional shares, competitors with a microarray market share, detailed microarray market segments, market trends, and opportunities, and any further data you may need to thrive in the microarray industry. This microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The microarray market size has grown strongly in recent years. It will grow from$5.19 billion in 2024 to $5.63 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to genomic research surge, rise in personalized medicine, pharmaceutical drug discovery, advancements in cancer research, biotechnology and life sciences expansion
The microarray market size is expected to see rapid growth in the next few years. It will grow to $8.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rapid growth in molecular diagnostics, emergence of precision medicine, increased adoption in agriculture, expansion of microbiome research, technological integration in healthcare. Major trends in the forecast period include enhancements in microarray data analysis tools, focus on biomarker discovery for neurological disorders, utilization in infectious disease research, adoption in functional genomics studies, increasing applications in drug discovery and development.
The future growth of the microarray market is anticipated to be driven by the increasing incidence of cancer cases. Cancer, characterized by uncontrolled cell growth and spread to other parts of the body, is on the rise due to factors such as established risk factors, exposure to specific chemicals, an aging population, and prevalent cancers such as breast cancer, lung cancer, and bronchial cancer. Microarray technology plays a crucial role in cancer research by enabling the identification of changes in gene expression associated with the disease. For example, the American Cancer Society estimates that around 9,910 children under the age of 15 will be diagnosed with cancer in the US in 2023, with approximately 1,040 children expected to succumb to the disease. Therefore, the increasing incidence of cancer cases is a key driver for the growth of the microarray market.
The expanding pharmaceutical industry is expected to drive the growth of the microarray market in the future. This sector encompasses the discovery, development, and production of drugs and medicines by both governmental and private organizations. Microarray technology is utilized within the pharmaceutical industry for detailed analysis of gene expression, genetic variations, and molecular interactions, supporting advanced research in drug discovery, development, and personalized medicine. For instance, in May 2024, data from the UK Health Accounts for 2022 and 2023, published by the UK Office for National Statistics, indicated that total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, a substantial rise compared to the 0.9% growth observed in 2022. Thus, the growth of the pharmaceutical industry is propelling the microarray market forward.
A noteworthy trend in the microarray market is the emphasis on product innovation by major market players. These companies are actively working on creating innovative products to strengthen their market position. For instance, in August 2023, Thermo Fisher Scientific, Inc., a US-based supplier of analytical instruments, life sciences solutions, and biotechnology services, launched the Applied Biosystems CytoScan HD Accel array. This chromosomal microarray is designed to enhance productivity, efficiency, and profitability in cytogenetic research labs, boasting an industry-leading two-day turnaround time. It offers comprehensive analysis of the entire human genome with enhanced coverage across 5,000 critical genomic regions, providing valuable insights into chromosomal variants for applications such as prenatal and postnatal research, as well as cancer-related studies.
Leading companies in the microarray market are focusing on the development of chromosomal microarrays to solidify their market position. Chromosomal Microarray Analysis (CMA) is considered a transformative technology in genomic medicine, significantly advancing diagnostic capabilities. For instance, in August 2023, Thermo Fisher Scientific Inc. introduced the Applied Biosystems CytoScan HD Accel array, contributing to improved productivity, efficiency, and profitability in cytogenetic research labs. This microarray facilitates comprehensive analysis of chromosomal variants for a broad range of research applications, including prenatal, postnatal, and oncology studies.
In May 2024, Bruker, a U.S.-based manufacturer of analytical instrumentation and scientific solutions, acquired NanoString's business for an undisclosed sum. This acquisition is intended to bolster Bruker's position in the life sciences sector and enhance its portfolio of analytical tools and solutions. NanoString is a U.S.-based biotechnology company known for producing DNA and protein microarrays as well as biosensors.
Major companies operating in the microarray market include Agilent Technologies Inc., Arrayit Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, GE Healthcare Inc., Illumina Inc., Merck KGaA, Microarray Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Molecular Devices LLC, RayBiotech Life Inc., NextGen Sciences Inc., PathogenDx Inc., Schott Minifab AG, Full Moon Biosystems Inc., CapitalBio Technology Co. Ltd., Roche Diagnostics, Ltd., BioGenomics Limited, BioMicro Systems Inc., Biostatus Limited, Biotechrabbit GmbH, Affymetrix Inc., SCIENION AG, INanoBio Inc.
North America was the largest region in the microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global microarray market report during the forecast period. The regions covered in the microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The microarray market consists of revenues earned by entities by providing services such as genotyping and methylation array services, analytical protein microarray, functional protein array, reverse-phase protein array, and peptide microarray. The value of associated goods sold by the service provider or incorporated into the service providing is included in the market value. The microarray market also includes sales of microarray slides or chips and priming, microarray fluorescence and colorimetric scanners, printers, hybridization stations or DNA and RNA assays, whole genome sequencing, cDNA Microarray, BAC microarray, oligo microarray, which are used in providing microarray services. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Microarray Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microarray market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.